This is a very interesting point of view about the Young Academic Urologists group about the use of SBRT for primary kidney cancer. This is a very interesting treatment option, especially for those patients who are poor candidates for partial nephrectomy. It’s a non-invasive treatment option. It may come with an especially high rate of local control and low rate of adverse events after treatment...
This is a very interesting point of view about the Young Academic Urologists group about the use of SBRT for primary kidney cancer. This is a very interesting treatment option, especially for those patients who are poor candidates for partial nephrectomy. It’s a non-invasive treatment option. It may come with an especially high rate of local control and low rate of adverse events after treatment. So it will be, we hope, that it will be very very useful in the near future.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.